Improved Macrophage Enrichment from Mouse Skeletal Muscle

Materials and Reagents

1. 100 mm Falcon^TM bacteriological Petri dishes with lid (Fisher Scientific, catalog number: 08-757-100D)

2. GentleMACS C-tubes (Miltenyi Biotec, catalog number: 130-093-237 or 130-096-334)

3. 5 mL Falcon^TM polypropylene round-bottomed tubes (Corning, catalog number: 352063)

4. 15 mL Falcon^TM tubes

5. 50 mL Falcon^TM tubes

6. 1.5 mL Eppendorf^TM tubes

7. Polystyrene containers; “sticky” for cells but could be used after BSA coating

8. PluriStrainer, 50 µm (pluriSelect, catalog number: 43-50050-01)

9. 10 mL syringe, Luer-Lok tip (BD, catalog number: 309604)

10. 20G × 1.5" blunt tip dispensing fill needles (CML Supply, catalog number: 901-20-150)

11. Countess^TM cell counting chamber slides (Invitrogen, catalog number: C10228)

12. Skeletal muscles from the hind limbs of 3-month-old and 18-month-old C57BL/6J mice (see below)

13. 70% ethanol

14. DMEM (ThermoFisher, catalog number: 11965-092). Store at 4 °C. Shelf life is 12 months from date of manufacture

15. Fetal bovine serum, heat inactivated (ThermoFisher, catalog number: 10438-026). Store at -20 °C. Shelf life is two years from date of manufacture

16. Penicillin and streptomycin solution (10,000 U/mL) (100×) (Thermo Fisher Scientific, catalog number: 15140122). Store at -20 °C. Shelf life is 12 months from date of manufacture

17. PBS, pH 7.2 (ThermoFisher, catalog number: 20012-027), free of Ca²⁺ and Mg²⁺. Store at 4 °C

18. RNAseZAP^TM zaps (Ambion, catalog number: 9786-9788)

19. Skeletal Muscle Dissociation kit (Miltenyi Biotec, catalog number: 130-098-305). Make aliquots for enzymes P, D, and A, and store them at -20 °C immediately after arrival. Shelf life is six months after aliquot

20. Debris removal solution (Miltenyi Biotec, catalog number: 130-109-398). Protect from light and store at 4 °C. Expiration date is labeled on the vial

21. Red blood cell lysis solution (Miltenyi Biotec, catalog number: 130-094-183). Protect from light and store at 4 °C. Expiration date is labeled on the vial

22. Auto MACS^TM rinsing solution (Miltenyi Biotec, catalog number: 130-091-222). Protect from light and store at room temperature. Expiration date is labeled on the bottle

23. MACS^TM BSA stock solution (Miltenyi Biotec, catalog number: 130-091-376). Protect from light and store at 4 °C. Expiration date is labeled on the bottle. After opening, the solution should be used within three days

24. 0.5 M EDTA (ThermoFisher, catalog number: 15575020). Store at room temperature

25. Trypan Blue solution (Invitrogen, catalog number: T10282). Store at room temperature

26. Antibodies: All antibodies and isotype controls from Biolegend should be stored undiluted at 4 °C and protected from light. Do not freeze. Shelf life is approximately two years

    1. PE anti-mouse/human CD11b antibody (Biolegend, catalog number: 101208, Clone M1/70)

    2. PE Rat IgG2b, κ Isotype Ctrl antibody (Biolegend, catalog number: 400607, Clone RTK4530)

    3. APC anti-mouse CD45 antibody (Biolegend, catalog number: 103111, Clone 30-F11)

    4. APC Rat IgG2b, κ Isotype Ctrl antibody (Biolegend, catalog number: 400611, RTK4530)

    5. FITC anti-mouse CD206 (MMR) antibody (Biolegend, catalog number: 141703, Clone C068C2)

    6. FITC Rat IgG2a, κ Isotype Ctrl antibody (Biolegend, catalog number: 400505, Clone RTK2758)

27. TruStain FcX^TM (anti-mouse CD16/32) antibody (Fc blocker) (Biolegend, catalog number: 101319). Store undiluted at 4 °C and protected from light

28. Fixable Viability Dye eFluor^TM 780 (Invitrogen, catalog number: 65-0865-14). Store at -80 °C and protect from light and moisture. Expiration date is labeled on the vial

29. DMEM-I and DMEM-II medium (see Recipes)

30. Digestive enzymes (see Recipes)

31. PEB buffer for cell isolation and flow cytometry (see Recipes)

32. Reagent combination to label macrophages for flow cytometry (see Recipes)

Equipment

1. Dissection tools: forceps, scalpels, and scissors

2. Pipettes

3. -80 °C freezer, -20 °C freezer, 4 °C refrigerator

4. GentleMACS^TM Octo Dissociator with heaters (Miltenyi Biotec, catalog number: 130-096-427)

5. Countess^TM II FL automated cell counter (Invitrogen, catalog number: AMQAF1000)

6. BD FACSCanto^TM II Cell Analyzer (BD, catalog number: REF338960)

7. Centrifuge 5702R (Eppendorf, catalog number: 022626205)

8. Centrifuge 5415R (Eppendorf, catalog number: 22-62-140-8)

Procedure

Note: The following protocol was designed for isolating mononuclear cells from skeletal muscle from two adult C57BL/6J mice.

1. Muscle preparation

   1. Decontaminate the tools for muscle dissection, including forceps, scalpels, and scissors, with RNaseZAP^TM wipes and rinse thoroughly with double-distilled water (ddH₂O). Decontaminate the procedure area by spraying with 70% ethanol.

   2. Prepare three 100 mm Petri dishes, each containing 10 mL DMEM-I (see Recipes). Place on ice for washing and trimming of isolated muscles. To collect dissected muscles from two mice, prepare two 50 mL Falcon tubes, each containing 5 mL of DMEM-I, and place on ice.

   3. Sacrifice a mouse by cervical dislocation or CO₂ asphyxiation and spray 70% ethanol over the entire mouse. Incise the skin at the ankle and peel off the skin from the hind limb. Dissect out all muscles surrounding the femur, tibia, and fibula (Figure 1A), and place into the 100 mm dishes containing DMEM-I. Cut out the fat, blood vessels, and tendons under a dissection microscope. Collect the trimmed muscles in the 50 mL Falcon tube containing DMEM-I; weigh the tube before and after sampling and record the muscle weight. Two hind limbs from an adult mouse provide approximately 1 g of muscle. Collect the muscles from the second mouse following the same procedure.

   4. Cut and slice the harvested muscles with scissors on ice, leaving 1–2 mL of DMEM-I on the Petri dish and removing the rest. Holding one end of a piece of muscle with forceps, use the scissors to cut the muscle into small pieces (approximately 1 mm³ fragments). After cutting, gather all the muscle pieces in the center of the dish and mince with scissors for an additional 2–3 min [Figure 1B (a)].

      
      

2. Mononuclear cell isolation

   1. Transfer the minced muscle tissues from one mouse into two C-tubes containing the enzyme mix (5 mL each) and close the tubes tightly.

   2. Mount the C-tubes onto the GentleMAC Octo Dissociator with heaters [Figure 1B (b)]. Choose the 37C-mr-SMDK-2 program. Start the digestion, which takes approximately 1.5 h.

   3. After digestion, briefly centrifuge the C-tubes [Figure 1B (c)]. At this step, combine the two C-tubes containing muscle suspensions that were dissected from the same mouse (5 + 5 = 10 mL) into one tube. Use a 10 or 15 mL syringe and a 20G blunt needle (pre-washed with 70% ethanol and distilled water or with DMEM-I) to slowly aspirate and eject the muscle suspension 10 times. Eject the suspension toward the wall of the tube to avoid foaming. This step further breaks down the tissue debris and increases cell yield.

   4. Add 10 mL of DMEM-II to each suspension to dilute and deactivate the enzymes. Pipette the suspension onto a cell strainer (50 µm mesh size) and collect the flowthrough into a 50 mL Falcon tube. Wash each strainer with 10 mL of DMEM-II twice. Use a 200 µL pipette to collect any remaining liquid from the underside of the strainer. Each tube will contain 40 mL cell suspension.

   5. Discard the strainer and centrifuge the cell suspension at 600 × g for 15 min at room temperature. A clear pellet will be visible at the bottom of the tube [Figure 1B (d)]. Discard the supernatant completely. Dissolve the pellet in 1 mL DMEM-II and transfer to a 1.5 mL Eppendorf tube.

   6. Centrifuge at 500 × g and 4 °C for 10 min in a bench-top centrifuge. Discard the supernatant and resuspend the pellet in 0.5 mL cold PBS. Place on ice.

      
      

3. Debris removal

   Note: This step efficiently removes fiber debris from the digested skeletal muscles and significantly improves the purity of mononuclear cells (Figure 1C).

   1. Carefully transfer the cell suspension to a 15 mL Falcon tube containing 5.7 mL of cold (4 °C) PBS (0.5 mL of cell suspension + 5.7 mL of PBS = 6.2 mL).

   2. Add 1.8 mL of cold debris removal solution; mix well by slowly pipetting up and down 10 times using a 10 mL pipette.

   3. Slightly tilt the tube and very slowly and gently overlay the cell suspension with 4 mL of cold PBS. Ensure that the PBS and the cell suspension phases do not mix.

   4. Centrifuge at 3,000 × g and 4 °C for 10 min. Discard the supernatant completely; this contains tissue debris [Figure 1C (a)]. The cell pellet at the bottom contains the mononuclear cells [Figure 1C (b)].

   5. Add cold PBS to a final volume of 15 mL. Gently invert the tube three times. Do not vortex.

   6. Centrifuge at 1,000 × g and 4 °C for 10 min. Discard the supernatant completely.

   7. Resuspend cells in 0.5 mL of PEB (see Recipes) by pipetting gently and slowly. Place on ice.

      
      

4. Red blood cell lysis

   1. Make 10 mL of 1× red blood cell lysis solution by diluting 10× lysis solution with double-distilled water (ddH₂O). Do not use deionized water (including deionized DEPC water). Store at room temperature.

   2. Mix one volume of cell suspension with 10 volumes of 1× red blood cell lysis solution (e.g., 0.5 mL of cell suspension + 5 mL of 1× lysis solution) in a 15 mL tube. Vortex for 5 s and incubate for 2 min at room temperature. Longer incubation may damage the cells.

   3. Centrifuge at 500 × g for 10 min at room temperature [Figure 1C (c)]. Discard the supernatant completely and resuspend the pellet in 0.5 mL of PEB. Place cells on ice.

   4. Mix 5 µL cells with 5 µL of Trypan Blue and count the number of cells using the Countess^TM machine. Approximately two million live mononuclear cells can be obtained from a mouse using the above procedure.

      
      

      
      Figure 1. Outline of macrophage isolation from mouse skeletal muscle. (A) Hind limb after muscle harvest. (B) Minced muscle from mouse hind limbs (a), cell dissociator (b), digested muscle in a C-tube (c), and cell pellet after centrifugation (d). (C) Debris removed by the debris removal solution (a), cell pellet after debris removal (b), cell pellet after red cell removal (c), and cells after sorting (d, 20× brightfield image).

      
      

5. Flow cytometry analysis of isolated mononuclear cells

   For analytical studies, evenly divide approximately two million cells into nine 1.5 mL Eppendorf tubes (50 μL in each), including a tube with unstained live cells, a tube with heat-induced dead cells, and tubes with isotype controls, single antibody controls, or combined antibodies. Add viability dye eFluor 780, Fc blocker, isotype control, or antibodies to each tube as explained below.

   
   

6. Procedures for staining

   Immunofluorescence staining for surface marker proteins enables us to identify specific immune cell populations. To confirm the enrichment of macrophages, we stained using three antibodies that recognized leukocytes (CD45), myeloid lineage cells including macrophages (CD11b), and M2 macrophages (CD206). See Table 1 for reagent combination.

   1. Add 50 µL of PEB to tube 1 (unstained) and place on ice.

   2. Incubate tube 2 at 65 °C for 10 min to generate the dead cell control. Subsequently, add 950 µL of PEB to bring the volume to 1 mL. Place on ice.

   3. Add 950 µL of PEB to the remaining tubes to bring the volume to 1 mL. Add 1 µL of viability dye (eFluor 780) to tubes 2, 3, 5, 7, and 9 (tubes 3, 5, and 7 are IgG isotype controls). Mix immediately by inverting the tubes 5–10 times. Incubate for 10 min at 4 °C.

   4. Centrifuge tubes 3, 5, 7, and 9 at 500 × g for 5 min, discard the supernatants, and resuspend in 1 mL of PEB. Centrifuge tube 2 at 12,000 × g and 4 °C for 5 min, discard the supernatant, and resuspend the pellet in 100 µL of PEB. Place tube 2 on ice.

   5. Add 1 µL of Fc blocker to tubes 3–9 and gently vortex for 1 s; repeat three times. Incubate for 5 min at room temperature (~25 °C).

   6. Centrifuge tubes 3–9 at 500 × g and 4 °C for 5 min. Discard supernatants and resuspend the pellet in 100 µL of PEB.

   7. Add 1 µL of IgG-PE, 1 µL of IgG-APC, or 1 µL of IgG-FITC to tubes 3, 5, and 7, respectively.

   8. Add 1 µL of CD11b-PE antibody, 1 µL of CD45-APC antibody, or 1 µL of CD206-FITC antibody to tubes 4, 6, and 8, respectively (tubes 4, 6, and 8 are for compensation). Add 1 µL of CD11b-PE, 1 µL of CD45-APC, and 1 µL of CD206-FITC to tube 9. Gently vortex for 1 s and repeat three times. Incubate for 40 min at 4 °C.

   9. Centrifuge tubes 3–9 at 500 × g and 4 °C for 5 min, discard the supernatant and resuspend the pellet in 500 µL of PEB. Gently vortex for 1 s and repeat three times.

   10. Spin down tubes 3–9 at 500 × g and 4 °C for 5 min, aspirate the supernatant and resuspend the cells in 100 µL of PEB. Cells are ready for flow cytometry analysis. Figure 2 shows the results of flow cytometry analysis of isolated mononuclear cells.

       
       

       
       Figure 2. Flow cytometry analysis of isolated mononuclear cells. (A) Isolated mononuclear cells from young and old skeletal muscle were gated in a Forward/Side scatter plot. (B) Gated cells (from A) were further analyzed for CD45 and CD11b expression. CD45⁺/CD11b⁺ cells were separated from the main cell population (left, gate Q6). The double-positive cells accounted for 7.58% of the total cells in the young preparations and 6.28% in the old preparations (left). CD45⁺ cells accounted for 9.87% of the total cells in the young preparations and 8.24% in the old preparations (center). CD11b⁺ cells accounted for 9.21% of the total cells in the young preparations and 7.15% in the old preparations (right). CD11b⁺ cells were clearly separated from the main population and almost all CD11b⁺ cells were CD45⁺. (C) Putative M2 macrophage marker CD206 was highly expressed (gate Q2) in 27.7% of CD11b⁺ cells (gates Q2+Q3) in the young preparations (left) and in 32.1% of CD11b⁺ cells in the old preparations (right). BD FACSCanto^TM II cell analyzer and FlowJo 10 software were used for analysis.

Notes

1. Here, we tested a commercial skeletal muscle dissociation kit combined with a programmable tissue dissociator and added a debris removal step. This protocol allowed the isolation of high-purity skeletal muscle macrophages. We generally obtain approximately two million live mononuclear cells from two hind limbs of a mouse, among which ~5–9% of cells are CD11b⁺/CD45⁺. This number is sufficient for FACS and single-cell transcriptomics analyses.

2. Several steps in our protocol were included to improve the purity and yield of macrophages. Firstly, the combination of tissue weight and enzyme mix affects cell yield. In our experience, 0.5 g muscle per 5 mL enzyme mix provided superior muscle digestion and cell yield as compared with 1 g muscle per 5 mL enzyme mix. Hence, we use two C-tubes, each containing approximately 0.5 g muscle and 5 mL enzyme mix, for one mouse. Secondly, we compared two digestion programs—37C-mr-SMDK-1 (1 h) and 37C-mr-SMDK-2 (1.5 h)—in a GentleMAC octo dissociator with heaters. The 1.5-h program provided a more thorough digestion and better cell yield. Thirdly, the debris removal solution effectively removed most of fiber debris, which allowed for much cleaner cell preparations. We highly recommend the debris removal steps.

3. Perfusing mice with saline solution through the inferior vena cava before sacrifice can be performed to reduce the presence of circulating immune cells in the skeletal muscle preparation.

4. Splenocytes, which can be easily harvested from the same mouse, are another option for generating dead cells.

5. Staining for additional markers, e.g., F4/80 and MHCII, will help to confirm macrophage specificity.

Recipes

1. Medium

   1. DMEM-I

      DMEM containing 1× penicillin and streptomycin solution. Store at 4 °C. Use within one month of preparation.

   2. DMEM-II

      DMEM-I supplemented with 5% heat-inactivated fetal bovine serum. Store at 4 °C. Use within one month of preparation.

      
      

2. Digestive enzymes

   A skeletal muscle dissociation kit (see Reagents) was used for mononuclear cell isolation. Upon arrival of the kit, reconstitute and aliquot enzymes D, P, and A, and store at -20 °C.

   1. Prepare an enzyme mix for cell dissociation. Remove the enzymes from the -20 °C freezer and place at room temperature (~25 °C) for 5–10 min. An enzyme master mix will be prepared first. This master mix must be freshly prepared each time.

   2. Each GentleMACS C-tube will include 4.7 mL of DMEM supplemented with:

      1× antibiotics

      200 μL of enzyme D

      50 μL of enzyme P

      36 μL of enzyme A

      Total 5 mL

   3. Make 20 mL of enzyme master mix for four C-tubes to digest muscles from two mice, as follows:

      20.21 mL of DMEM

      860 μL of enzyme D

      215 μL of enzyme P

      154.8 μL of enzyme A (one tube × 4.3)

      Total 21.65 mL

   4. Resuspend the enzyme master mix.

   5. Add 5 mL of enzyme mix to each of the four GentleMACS C-tubes and place on ice. Use two C-tubes to digest skeletal muscles from one mouse. Given that approximately 1 g of skeletal muscle can be obtained from two hind legs of a mouse, approximately 0.5 g muscle tissues will be digested in 5 mL of enzyme mix in each C-tube.

      
      

3. Buffers for flow cytometry analysis

   PEB buffer:

   1,450 mL of Auto MACS rinsing solution

   150 mL of MACS BSA stock solution

   24 mL of 0.5 M EDTA

   The PEB buffer contains 1% BSA and 10 mM of EDTA

   Store at 4 °C. Use within three months of preparation.

   
   

4. Reagent combination to label macrophages for flow cytometry

   Evenly divide approximately two million cells into nine 1.5 mL Eppendorf tubes (50 μL in each). Tube 1 contains unstained live cells and tube 2 contains heat-induced dead cells. Tubes 3, 5, and 7 contain isotype controls, and tubes 4, 6, and 8 contain single antibody controls. Tube 9 contains the combined antibodies. Add eFluor 780, Fc blocker, isotype control, or antibodies to each tube as described in Table 1. See Procedures for staining (Section F) for more details.

   
   

   Table 1. Reagent combination for staining

   Tubes	Viability Dye (eFluor 780)	Fc blocker	Isotype control	Antibody
   1
   2	1 µL
   3	1 µL	1 µL	1 µL (IgG-PE)
   4		1 µL		1 µL (CD11b-PE)
   5	1 µL	1 µL	1 µL (IgG-APC)
   6		1 µL		1 µL (CD45-APC)
   7	1 µL	1 µL	1 µL (IgG-FITC)
   8		1 µL		1 µL (CD206-FITC)
   9	1 µL	1 µL		1 µL (CD11b-PE) 1 µL (CD45-APC) 1 µL (CD206-FITC)

Acknowledgments

This work was supported by the Intramural Research Program of the National Institute on Aging. The authors thank Dr. Ramaiah Nagaraja for helpful technical assistance. This protocol derives from the main paper (Krasniewski et al, 2022).

Competing interests

The authors declare no competing interests.

Ethics

Animal use was approved by the Animal Care and Use Committee of the National Institute on Aging, NIH. Approved ID is 476-LGG-2024, which is effective until 2024.

References

1. Arnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K. and Chazaud, B. (2007). Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 204(5):1057-1069.
2. Chakarov, S., Lim, H. Y., Tan, L., Lim, S. Y., See, P., Lum, J., Zhang, X. M., Foo, S., Nakamizo, S., Duan, K., et al. (2019). Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches.Science 363(6432): eaau0964.
3. Cui, C. Y., Driscoll, R. K., Piao, Y., Chia, C. W., Gorospe, M. and Ferrucci, L. (2019). Skewed macrophage polarization in aging skeletal muscle. Aging Cell 18(6): e13032.
4. Cui, C. Y. and Ferrucci, L. (2020). Macrophages in skeletal muscle aging. Aging (Albany NY). 12(1):3-4
5. Gautier, E. L., Shay, T., Miller, J., Greter, M., Jakubzick, C., Ivanov, S., Helft, J., Chow, A., Elpek, K. G., Gordonov, S., et al. (2012). Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol 13(11): 1118-1128.
6. Gosselin, D., Link, V. M., Romanoski, C. E., Fonseca, G. J., Eichenfield, D. Z., Spann, N. J., Stender, J. D., Chun, H. B., Garner, H., Geissmann, F., et al. (2014). Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159(6): 1327-1340.
7. Ginhoux, F. and Guilliams, M. (2016). Tissue-Resident Macrophage Ontogeny and Homeostasis. Immunity 44(3): 439-449.
8. Hoeksema, M. A. and Glass, C. K. (2019). Nature and nurture of tissue-specific macrophage phenotypes. Atherosclerosis 281: 159-167.
9. Jaitin, D. A., Adlung, L., Thaiss, C. A., Weiner, A., Li, B., Descamps, H., Lundgren, P., Bleriot, C., Liu, Z., Deczkowska, A., et al. (2019). Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner. Cell 178(3): 686-698 e614.
10. Jensen, S. M., Bechshoft, C. J. L., Heisterberg, M. F., Schjerling, P., Andersen, J. L., Kjaer, M. and Mackey, A. L. (2020). Macrophage Subpopulations and the Acute Inflammatory Response of Elderly Human Skeletal Muscle to Physiological Resistance Exercise. Front Physiol 11: 811.
11. Kosmac, K., Peck, B. D., Walton, R. G., Mula, J., Kern, P. A., Bamman, M. M., Dennis, R. A., Jacobs, C. A., Lattermann, C., Johnson, D. L., et al. (2018). Immunohistochemical Identification of Human Skeletal Muscle Macrophages. Bio-protocol 8(12): e2883.
12. Kratofil, R. M., Kubes, P. and Deniset, J. F. (2017). Monocyte Conversion During Inflammation and Injury. Arterioscler Thromb Vasc Biol 37(1): 35-42.
13. Krasniewski, L. K., Chakraborty, P., Cui, C. Y., Mazan-Mamczarz, K., Dunn, C., Piao, Y., Fan, J., Shi, C., Wallace, T., Nguyen, C., et al. (2022). Single-cell analysis of skeletal muscle macrophages reveals age-associated functional subpopulations.eLife 11: e77974.
14. Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S. and Amit, I. (2014). Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159(6): 1312-1326.
15. Liu, L., Cheung, T. H., Charville, G. W. and Rando, T. A. (2015). Isolation of skeletal muscle stem cells by fluorescence-activated cell sorting. Nat Protoc 10(10): 1612-1624.
16. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. and Hill, A. M. (2000). M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol 164(12): 6166-6173.
17. Martinez, F. O., Sica, A., Mantovani, A. and Locati, M. (2008). Macrophage activation and polarization. Front Biosci 13: 453-461.
18. Rath, M., Muller, I., Kropf, P., Closs, E. I. and Munder, M. (2014). Metabolism via Arginase or Nitric Oxide Synthase: Two Competing Arginine Pathways in Macrophages. Front Immunol 5: 532.
19. Shapouri-Moghaddam, A., Mohammadian, S., Vazini, H., Taghadosi, M., Esmaeili, S. A., Mardani, F., Seifi, B., Mohammadi, A., Afshari, J. T. and Sahebkar, A. (2018). Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233(9): 6425-6440.
20. Tidball, J. G. (2011). Mechanisms of muscle injury, repair, and regeneration. Compr Physiol 1(4): 2029-2062.
21. Tidball, J. G. (2017). Regulation of muscle growth and regeneration by the immune system. Nat Rev Immunol 17(3): 165-178.
22. Underhill, D. M., Gordon, S., Imhof, B. A., Nunez, G. and Bousso, P. (2016). Elie Metchnikoff (1845-1916): celebrating 100 years of cellular immunology and beyond. Nat Rev Immunol 16(10): 651-656.
23. Walton, R. G., Kosmac, K., Mula, J., Fry, C. S., Peck, B. D., Groshong, J. S., Finlin, B. S., Zhu, B., Kern, P. A. and Peterson, C. A. (2019). Human skeletal muscle macrophages increase following cycle training and are associated with adaptations that may facilitate growth. Sci Rep 9(1): 969.
24. Wang, X., Sathe, A. A., Smith, G. R., Ruf-Zamojski, F., Nair, V., Lavine, K. J., Xing, C., Sealfon, S. C. and Zhou, L. (2020). Heterogeneous origins and functions of mouse skeletal muscle-resident macrophages. Proc Natl Acad Sci U S A 117(34): 20729-20740.
25. Wynn, T. A., Chawla, A. and Pollard, J. W. (2013). Macrophage biology in development, homeostasis and disease. Nature 496(7446): 445-455.
26. Yang, W. and Hu, P. (2018). Skeletal muscle regeneration is modulated by inflammation. J Orthop Translat 13: 25-32.